在2期CANDELA研究中,afliberept 8 mg治疗nAMD的临床结果。

IF 5.9 Q1 OPHTHALMOLOGY Ophthalmology. Retina Pub Date : 2025-09-01 Epub Date: 2025-04-01 DOI:10.1016/j.oret.2025.03.023
Jordana G. Fein MD , Priya S. Vakharia MD , A. Paul Chous OD , Rutvi Desai OD , Fabiana Q. Silva MD , Kimberly Reed OD , Alyson J. Berliner MD, PhD , Robert Vitti MD , Charles C. Wykoff MD, PhD
{"title":"在2期CANDELA研究中,afliberept 8 mg治疗nAMD的临床结果。","authors":"Jordana G. Fein MD , Priya S. Vakharia MD , A. Paul Chous OD , Rutvi Desai OD , Fabiana Q. Silva MD , Kimberly Reed OD , Alyson J. Berliner MD, PhD , Robert Vitti MD , Charles C. Wykoff MD, PhD","doi":"10.1016/j.oret.2025.03.023","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 9","pages":"Pages 915-918"},"PeriodicalIF":5.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study\",\"authors\":\"Jordana G. Fein MD , Priya S. Vakharia MD , A. Paul Chous OD , Rutvi Desai OD , Fabiana Q. Silva MD , Kimberly Reed OD , Alyson J. Berliner MD, PhD , Robert Vitti MD , Charles C. Wykoff MD, PhD\",\"doi\":\"10.1016/j.oret.2025.03.023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19501,\"journal\":{\"name\":\"Ophthalmology. Retina\",\"volume\":\"9 9\",\"pages\":\"Pages 915-918\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmology. Retina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468653025001526\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology. Retina","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468653025001526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在这项对CANDELA试验进行的事后分析中,接受8毫克阿弗利百普治疗的新生血管性老年性黄斑变性患者的眼部解剖和视觉效果均有所改善,这表明与2毫克阿弗利百普相比,阿弗利百普具有治疗优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmology. Retina
Ophthalmology. Retina Medicine-Ophthalmology
CiteScore
7.80
自引率
6.70%
发文量
274
审稿时长
33 days
期刊最新文献
Choroidal Amyloid Angiopathy with Fireworks Pattern on Late-Frames Indocyanine Green Angiography. Tetracycline-class Antibiotics for Proliferative Retinopathy Prevention: Still Too Many Unanswered Questions. Ultrasonographic Features of Morning Glory Syndrome and Peripapillary Staphyloma in Children: Associations With Retinal Detachment. Faricimab for Polypoidal Choroidal Vasculopathy: 48-Week Results from the Phase 3b/4 SALWEEN Trial. Large Choroidal Excavation in CDHR1-Associated Retinopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1